Neuronetics (STIM) Interest Coverage Ratio Growth (3y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -7.80% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -1.00% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 12.94% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -35.05% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.28% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -4.98% |
| 10 | Neuronetics | 3.26 Mn | -6.42 Mn | 16.15 Mn | 23.90% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.90% |
| Dec 31, 2025 | 37.32% |
| Sep 30, 2025 | 26.28% |
| Jun 30, 2025 | 30.60% |
| Mar 31, 2025 | 14.49% |
| Dec 31, 2024 | -0.18% |
| Sep 30, 2024 | 12.59% |
| Jun 30, 2024 | 13.82% |
| Mar 31, 2024 | 18.79% |
| Dec 31, 2023 | 3.01% |
| Sep 30, 2023 | -45.76% |
| Jun 30, 2023 | 2.62% |
| Mar 31, 2023 | -6.75% |
| Dec 31, 2022 | 2.88% |
| Sep 30, 2022 | -6.77% |
| Jun 30, 2022 | -19.94% |
| Mar 31, 2022 | -10.51% |
| Dec 31, 2021 | -2.51% |
| Sep 30, 2021 | -15.71% |
| Jun 30, 2021 | -4.92% |
| Mar 31, 2021 | -11.94% |
| Dec 31, 2020 | 22.81% |
| Sep 30, 2020 | 11.43% |
| Jun 30, 2020 | -24.27% |
| Mar 31, 2020 | -0.70% |